Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa dose-ranging study of DC-TAB in multiple sclerosis
2011-004475-36Phase 2Completed
- Sponsor
- Delta Crystallon B.V.
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of decitabine in multiple sclerosis (MS), sponsored by Delta Crystallon B.V.. Started Apr 2012; status: completed.
02
Drugs
decitabine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on 2011-004475-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004475-36.